Associated Papers
Open channel block of Kv1.5 channels by HMQ1611.
Dong C et al.
Frontiers in Pharmacology, 2022
Identification of Verapamil Binding Sites Within Human Kv1.5 Channel Using Mutagenesis and Docking Simulation.
Ding WG et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology, 2019
Regulation of human cardiac Kv1.5 channels by extracellular acidification.
Wang S et al.
Pflugers Archiv : European Journal of Physiology, 2016
Putative binding sites for arachidonic acid on the human cardiac Kv 1.5 channel.
Bai JY et al.
British Journal of Pharmacology, 2015
High-throughput analysis of drug binding interactions for the human cardiac channel, Kv1.5.
Karczewski J et al.
Biochemical Pharmacology, 2009
Structural basis for competition between drug binding and Kvbeta 1.3 accessory subunit-induced N-type inactivation of Kv1.5 channels.
Decher N et al.
Molecular Pharmacology, 2005
Molecular basis for Kv1.5 channel block: conservation of drug binding sites among voltage-gated K+ channels.
Decher N et al.
The Journal of Biological Chemistry, 2004
Regulation of N- and C-type inactivation of Kv1.4 by pHo and K+: evidence for transmembrane communication.
Li X et al.
American Journal of Physiology. Heart and Circulatory Physiology, 2003
Mutations throughout the S6 region of the hKv1.5 channel alter the stability of the activation gate.
Rich TC et al.
American Journal of Physiology. Cell Physiology, 2002
Distinct domains of the voltage-gated K+ channel Kv beta 1.3 beta-subunit affect voltage-dependent gating.
Uebele VN et al.
The American Journal of Physiology, 1998
Select a paper to view details